نتائج البحث - Ruth He

تنقيح النتائج
  1. 1
    Hepatocellular Carcinoma: Past and Present Challenges and Progress in Molecular Classification and Precision Oncology

    Hepatocellular Carcinoma: Past and Present Challenges and Progress in Molecular Classification and Precision Oncology حسب Philip Coffin, Aiwu Ruth He

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma

    Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma حسب Narayanan Sadagopan, Aiwu Ruth He

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Systemic therapy for advanced hepatocellular carcinoma: an update

    Systemic therapy for advanced hepatocellular carcinoma: an update حسب Jasmin Radhika Desai, Sebastian Ochoa, Petra Prins, Aiwu Ruth He

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Systemic Treatment for Advanced Hepatocellular Carcinoma

    Systemic Treatment for Advanced Hepatocellular Carcinoma حسب Mohamed Bouattour, Neil Mehta, Aiwu Ruth He, E. Cohen, Jean‐Charles Nault

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Advances in Immunotherapy for Transplant Oncology

    Advances in Immunotherapy for Transplant Oncology حسب Maen Abdelrahim, Abdullah Esmail, Aiwu Ruth He, Moh’d Khushman, Yaser Rayyan

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Editorial
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    The Role of Angiogenesis in Hepatocellular Carcinoma

    The Role of Angiogenesis in Hepatocellular Carcinoma حسب Michael A. Morse, Weijing Sun, Richard D. Kim, Aiwu Ruth He, Paolo Abada, Michelle Mynderse, Richard S. Finn

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion

    Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion حسب Laura Kulik, Leonardo Gomes da Fonseca, Aiwu Ruth He, Jordi Rimola, Andrea Wilson Woods, York Zöllner, Peter R. Galle

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Liver stem cells and hepatocellular carcinoma

    Liver stem cells and hepatocellular carcinoma حسب Lopa Mishra, Tanuj Banker, Joseph C. Murray, Stephen W. Byers, Arun Thenappan, Aiwu Ruth He, Kirti Shetty, Lynt B. Johnson, E. Premkumar Reddy

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection

    Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection حسب Neil J. Shah, Ghassan Al‐Shbool, Matthew Blackburn, Michael R. Cook, Anas Belouali, Stephen V. Liu, Subha Madhavan, Aiwu Ruth He, Michael B. Atkins, Geoffrey T. Gibney, Chul Kim

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer

    A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer حسب Michael J. Pishvaian, Hongkun Wang, Aiwu Ruth He, Jimmy J. Hwang, Brandon G. Smaglo, Sunnie S. Kim, Benjamin A. Weinberg, Louis M. Weiner, John L. Marshall, Jonathan R. Brody

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma

    SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma حسب Ling Lin, Shuyi Chen, Hua Wang, Bin Gao, Bhaskar Kallakury, Krithika Bhuvaneshwar, Katherine Cahn, Yuriy Gusev, Xue Wang, Yunan Wu, John L. Marshall, Xiuling Zhi, Aiwu Ruth He

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies

    A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies حسب Trivedi, Neel D., Armstrong, Samantha, Wang, Hongkun, Hartley, Marion, Deeken, John, Ruth He, A., Subramaniam, Deepa, Melville, Heather, Albanese, Chris, Marshall, John L., Hwang, Jimmy, Pishvaian, Michael J.

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling

    The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling حسب Li Lin, Rupen Amin, G. Ian Gallicano, Eric Glasgow, Wilma Jogunoori, J. Milburn Jessup, Michael Zasloff, John L. Marshall, Kirti Shetty, Lynt B. Johnson, Lopa Mishra, Aiwu Ruth He

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma

    Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma حسب Avijit Majumdar, Steven A. Curley, Xifeng Wu, Powel H. Brown, Jessica Hwang, Kirti Shetty, Zhi-Xing Yao, Aiwu Ruth He, Shulin Li, Lior H. Katz, Patrizia Farci, Lopa Mishra

    منشور في 2012
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer

    A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer حسب Michael J. Pishvaian, Rebecca Slack, Wei Jiang, Aiwu Ruth He, Jimmy J. Hwang, Amy Hankin, Karen Dorsch‐Vogel, Divyesh Kukadiya, Louis M. Weiner, John L. Marshall, Jonathan R. Brody

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer

    Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer حسب Neil H. Segal, Aiwu Ruth He, Toshihiko Doi, Ronald Levy, Shailender Bhatia, Michael J. Pishvaian, Rossano Cesari, Ying Chen, Craig B. Davis, Bo Huang, Aron D. Thall, Ajay K. Gopal

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Randomised efficacy and safety results for atezolizumab (Atezo) + bevacizumab (Bev) in patients (pts) with previously untreated, unresectable hepatocellular carcinoma (HCC)

    Randomised efficacy and safety results for atezolizumab (Atezo) + bevacizumab (Bev) in patients (pts) with previously untreated, unresectable hepatocellular carcinoma (HCC) حسب Matthew Man Pok Lee, Baek‐Yeol Ryoo, Chih‐Hung Hsu, Kazushi Numata, Stacey Stein, Wendy Verret, Stephen P. Hack, Jessica Spahn, B. Liu, Hesham Abdullah, Ruth He, Ki Hoon Lee

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies

    A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies حسب John F. Deeken, Rebecca Slack, Glen J. Weiss, Ramesh K. Ramanathan, Michael J. Pishvaian, Jimmy J. Hwang, Karen Lewandowski, Deepa S. Subramaniam, Aiwu Ruth He, Ion Cotarla, Aquilur Rahman, John L. Marshall

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    βII‐Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin

    βII‐Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin حسب Xiuling Zhi, Ling Lin, Shaoxian Yang, Krithika Bhuvaneshwar, Hongkun Wang, Yuriy Gusev, Mi‐Hye Lee, Bhaskar Kallakury, Narayan Shivapurkar, Katherine Cahn, Xuefei Tian, John L. Marshall, Stephen W. Byers, Aiwu Ruth He

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma

    Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma حسب Marie Kate Gurka, Christine M. Kim, Aiwu Ruth He, Aline Charabaty, Nadim Haddad, Jenna Turocy, Lynt B. Johnson, Patrick G. Jackson, Louis M. Weiner, John L. Marshall, Sean P. Collins, Michael J. Pishvaian, Keith Unger

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: